OAR 855-019-0120
Licensure


(1)

Before licensure as a pharmacist, an applicant must meet the following requirements:

(a)

Provide evidence from a school or college of pharmacy approved by the Board that they have successfully completed all the requirements for graduation and, starting with the graduating class of 2011, including not less than 1440 hours of School-based Rotational Internships as that term is defined in OAR 855-031-0005 (Definitions), and that a degree will be conferred;

(b)

Pass the North American Pharmacist Licensure Examination (NAPLEX) exam with a score of not less than 75. This score shall remain valid for only one year unless the Board grants an extension. A candidate who does not attain this score may retake the exam after a minimum of 45 days with a limit of three attempts in a 12 month period, not to exceed a lifetime maximum of 5 times.

(c)

Pass the Multistate Pharmacy Jurisprudence Examination (MPJE) exam with a score of not less than 75. The applicant may not take the MPJE until they have graduated from a school or college of pharmacy approved by the Board. A candidate who does not attain this score may retake the exam after a minimum of 30 days with a limit of three attempts in a 12 month period, not to exceed a lifetime maximum of 5 times. The MPJE score shall be valid for 6 months unless extended by the Board;

(d)

Complete an application for licensure, provide the Board with a valid e-mail address, and a fingerprint card or other documentation required to conduct a criminal background check.

(2)

A license, once obtained, will expire on June 30 in odd numbered years and must be renewed biennially.
855–019–0100
Application
855–019–0110
Definitions
855–019–0120
Licensure
855–019–0122
Renewal of Licensure as a Pharmacist
855–019–0123
Liability Limitations for Volunteers
855–019–0125
Coaching from Board and Staff
855–019–0130
Licensure by Reciprocity
855–019–0140
NAPLEX Score Transfer
855–019–0150
Foreign Pharmacy Graduates
855–019–0160
Nuclear Pharmacists
855–019–0170
Reinstatement of License
855–019–0171
Reinstatement of a Revoked or Surrendered License
855–019–0200
General Responsibilities of a Pharmacist
855–019–0205
Duty to Report
855–019–0210
Duties of the Pharmacist Receiving a Prescription
855–019–0220
Drug Utilization Review (DUR)
855–019–0230
Counseling
855–019–0240
Consulting Pharmacist Practice
855–019–0250
Medication Therapy Management
855–019–0260
Collaborative Drug Therapy Management
855–019–0265
Administration of Drugs
855–019–0270
Immunization Qualifications
855–019–0280
Immunization Protocols, Policies and Procedures
855–019–0290
Immunization Record Keeping and Reporting
855–019–0300
Duties of a Pharmacist-in-Charge
855–019–0310
Grounds for Discipline
855–019–0400
Contraceptives - Purpose
855–019–0405
Contraceptives - Definitions
855–019–0410
Prescriptive Practice Consultation
855–019–0415
Contraceptive - Training Program
855–019–0425
Contraceptive - Procedural Mandates
855–019–0430
Contraceptive - Prohibited Practices
855–019–0435
Contraceptive - Records
855–019–0460
Naloxone - Delivery of Care and Prescribing
855–019–0470
Emergency Insulin
Last Updated

Jun. 8, 2021

Rule 855-019-0120’s source at or​.us